Proud To Partner With:
Antaros Medical
Expertise Partner
Antaros Medical is pioneering imaging methods, using MRI* and PET**, to both design and deliver clinical imaging studies. Applied with our extensive experience and expertise in drug development and disease biology, our tailored solutions have helped our customers to solve complex problems to empower confident decision-making at every stage of clinical drug development, from small mechanistic studies to large scale studies. Disease areas: CV, renal & metabolic diseases and oncology.
Nordic Bioscience
Expertise Partner
Nordic Bioscience is a biotech company founded in 1992 located in Herlev, Denmark. Nordic Bioscience is focused on the development, testing and validation of new blood based biochemical markers for diagnosis and prognosis of fibrotic and inflammatory diseases. We are a science-driven company that invests heavily in developing blood-based precision medicine solutions for the pharmaceutical industry as well as for patient care through our research and development division. Our central laboratory division offers a complete portfolio of central laboratory services as well as novel biomarker measures.
Perspectum
Expertise Partner
Perspectum delivers leading digital technologies for diagnosis and targeted treatment of patients with metabolic diseases and multi-organ pathologies. Our advanced imaging and digital pathology portfolio and proprietary biomarkers provide accurate, quantifiable insights into the mechanisms and efficacy of therapies. With experience in over 60 commercial clinical trials in MASH and 30 late phase trials, Perspectum is a true partner for design and delivery of smarter, faster and more cost effective MASH clinical trials.
Summit Clinical Research
Hosting Partner
Summit Clinical Research is an Integrated Research Organization which brings together experienced research sites with proven success in the Metabolic Dysfunction-associated Steatohepatitis (MASH) research space. Our mission is to execute comprehensive site recruitment and engagement strategy to achieve the target patient enrollment goal efficiently and cost-effectively within the projected timelines.
We believe patients who participate in clinical trials are partners in their own healthcare. This philosophy is shared by our network of experienced MASH research sites.
Clinical Ink
Program Partner
Clinical ink is the global life science company bringing data, technology, and patient-centric research together. Our deep therapeutic-area expertise in metabolism, coupled with Direct Data Capture, eCOA/ePRO, eConsent, telehealth, advanced digital biomarkers including continuous glucose monitoring, and behavioral phenotyping to predict and mitigate non-adherence and dropout, all support the next generation of clinical trials in metabolic liver disease, and ultimately, the clinical management of patients.
Almac
Innovation Partner
Almac Diagnostic Services support global pharma and biotech companies with their biomarker strategies from biomarker discovery through to companion diagnostic partnerships. Almac has clinical and research laboratories in Europe and the USA, alongside strategic partnerships in China, enabling us to support global studies. The services offered fall into three main categories: Genomic Services, Clinical Trial Assays & Companion Diagnostics.
Almac Diagnostic Services has experience supporting biomarker strategies across multiple chronic disease indications including MASH / MAFLD. Almac has developed PNPLA3 and HSD17B13 Clinical Trial Assays that are analytically validated for test delivery.
Physiogenex
Innovation Partner
For >20 years, we have been evaluating the efficacy of our clients' drugs using gold-standard experiments in our validated preclinical models. Our customers benefit from our experience in drug development and expertise in metabolic diseases, as demonstrated by our numerous co-publications with our industrial partners.
Our expertise - your success.
Aragen
Exhibition Partner
Aragen Life Sciences is a leading R&D and manufacturing solutions provider for the life sciences industries worldwide. Aragen offers end-to-end integrated or standalone solutions to advance small and large molecule programs from concept to commercialization. Established in 2001, the Company operates through a global network of six sites with a team of 3800+ employees and 450+ PhDs. Its expertise and experience have enabled over 450 customers (including 7 of the top 10 pharma companies globally) in advancing their research programs from early discovery through development and commercialization. Aragen’s innovative mindset, infrastructure, flexible business models, a clear purpose, and proprietary project management platform have enabled it to effectively scale and service large pharma, biotech, agrochemical, and animal health industries globally.
LifeNet Health
Exhibition Partner
LifeNet Health LifeSciences gives healing every advantage by providing research solutions that empower groundbreaking discoveries around the world. Our goal is to improve health and safety for humankind by providing all-human cells, in vitro physiological systems, biospecimens for research, and cytotoxicity services. We support scientists in the pharmaceutical, biotech, agriscience, food safety, and cosmetic industries.
HepQuant
Exhibition Partner
HepQuant develops minimally invasive, quantitative liver function tests. Our technology has been used in over 38 clinical trials, and we have worked with over 23 leading pharmaceutical companies. The HepQuant DuO™ Test, a Laboratory Developed Test (LDT), involves only a single oral dose of stable isotope-labeled cholate followed by two blood draws. This test produces the disease severity index (DSI), hepatic reserve (HR%), and estimates portal-systemic shunting (SHUNT%). Since its inception in 2023, 8 related peer-reviewed publications have been published. HepQuant DuO is now launching to the clinic and being implemented in pharmaceutical trials.
Gubra
Event Partner
Gubra offers expert preclinical research services enabling pharmaceutical and biotech companies to advance their drug development pipeline. Our capabilities in preclinical studies include in vivo pharmacology, ex vivo assays, drug profiling, histology, stereology and whole brain and organ imaging. We employ a combination of unique techniques to profile drug candidates in a wide array of clinically translatable research models.